Acute Haemodynamic Impact of an IV Glucose-injection

Sponsor
University Hospital, Ghent (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00426114
Collaborator
(none)
0

Study Details

Study Description

Brief Summary

Patients with peritoneal dialysis will be administered an IV glucose-injection to evaluate the haemodynamic impact of this injection. The patients will be matched with healthy volunteers.

Condition or Disease Intervention/Treatment Phase
  • Drug: Administration of an IV glucose-injection
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Acute Haemodynamic Impact of an IV Glucose-injection

Outcome Measures

Primary Outcome Measures

  1. Haemodynamic parameters []

  2. Glycemia []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years old

  • Stable clinical condition

  • Either peritoneal dialysis (at least one month) either matched healthy subject

Exclusion Criteria:
  • Heart Failure

  • Diabetes requiring insulin treatment

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Ghent

Investigators

  • Principal Investigator: Wim Van Biesen, MD, PhD, University Hospital, Ghent

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00426114
Other Study ID Numbers:
  • 2007/016
First Posted:
Jan 24, 2007
Last Update Posted:
Jul 7, 2021
Last Verified:
Jul 1, 2021

Study Results

No Results Posted as of Jul 7, 2021